Answer
Sinus bradycardia has been reported after marketing. Tell the clinical team promptly about faintness, marked weakness, breathlessness or awareness of an unusually slow heartbeat.
Sources for this answer
- Veklury 100 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.